The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Subcutaneous Injection-Global Market Insights and Sales Trends 2025
Synopsis
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.
The global Subcutaneous Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Subcutaneous Injection in various end use industries. The expanding demands from the Hospital, Clinic, Laboratory and Others, are propelling Subcutaneous Injection market. Subcutaneous Injection Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous Injection Drug segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Subcutaneous Injection market, driven by demand from China, the second largest economy with some signs of stabilising, the Subcutaneous Injection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Subcutaneous Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Subcutaneous Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Subcutaneous Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Subcutaneous Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Subcutaneous Injection covered in this report include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc.
The global Subcutaneous Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.，Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Global Subcutaneous Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Injection market, Segment by Type:
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Global Subcutaneous Injection market, by Application
Hospital
Clinic
Laboratory
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Subcutaneous Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.
The global Subcutaneous Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Subcutaneous Injection in various end use industries. The expanding demands from the Hospital, Clinic, Laboratory and Others, are propelling Subcutaneous Injection market. Subcutaneous Injection Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous Injection Drug segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Subcutaneous Injection market, driven by demand from China, the second largest economy with some signs of stabilising, the Subcutaneous Injection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Subcutaneous Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Subcutaneous Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Subcutaneous Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Subcutaneous Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Subcutaneous Injection covered in this report include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc.
The global Subcutaneous Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.，Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Global Subcutaneous Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Injection market, Segment by Type:
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Global Subcutaneous Injection market, by Application
Hospital
Clinic
Laboratory
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Subcutaneous Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Subcutaneous Injection
1.1 Subcutaneous Injection Market Overview
1.1.1 Subcutaneous Injection Product Scope
1.1.2 Subcutaneous Injection Market Status and Outlook
1.2 Global Subcutaneous Injection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Subcutaneous Injection Market Size by Region (2018-2029)
1.4 Global Subcutaneous Injection Historic Market Size by Region (2018-2023)
1.5 Global Subcutaneous Injection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Subcutaneous Injection Market Size (2018-2029)
1.6.1 North America Subcutaneous Injection Market Size (2018-2029)
1.6.2 Europe Subcutaneous Injection Market Size (2018-2029)
1.6.3 Asia-Pacific Subcutaneous Injection Market Size (2018-2029)
1.6.4 Latin America Subcutaneous Injection Market Size (2018-2029)
1.6.5 Middle East & Africa Subcutaneous Injection Market Size (2018-2029)
2 Subcutaneous Injection Market by Type
2.1 Introduction
2.1.1 Subcutaneous Injection Equipment
2.1.2 Subcutaneous Injection Drug
2.1.3 Others
2.2 Global Subcutaneous Injection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Subcutaneous Injection Historic Market Size by Type (2018-2023)
2.2.2 Global Subcutaneous Injection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Subcutaneous Injection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Subcutaneous Injection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Subcutaneous Injection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Subcutaneous Injection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Subcutaneous Injection Revenue Breakdown by Type (2018-2029)
3 Subcutaneous Injection Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Laboratory
3.1.4 Others
3.2 Global Subcutaneous Injection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Subcutaneous Injection Historic Market Size by Application (2018-2023)
3.2.2 Global Subcutaneous Injection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Subcutaneous Injection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Subcutaneous Injection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Subcutaneous Injection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Subcutaneous Injection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Subcutaneous Injection Revenue Breakdown by Application (2018-2029)
4 Subcutaneous Injection Competition Analysis by Players
4.1 Global Subcutaneous Injection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2022)
4.3 Date of Key Players Enter into Subcutaneous Injection Market
4.4 Global Top Players Subcutaneous Injection Headquarters and Area Served
4.5 Key Players Subcutaneous Injection Product Solution and Service
4.6 Competitive Status
4.6.1 Subcutaneous Injection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Becton Dickinson
5.1.1 Becton Dickinson Profile
5.1.2 Becton Dickinson Main Business
5.1.3 Becton Dickinson Subcutaneous Injection Products, Services and Solutions
5.1.4 Becton Dickinson Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.1.5 Becton Dickinson Recent Developments
5.2 Daiichi Sankyo
5.2.1 Daiichi Sankyo Profile
5.2.2 Daiichi Sankyo Main Business
5.2.3 Daiichi Sankyo Subcutaneous Injection Products, Services and Solutions
5.2.4 Daiichi Sankyo Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.2.5 Daiichi Sankyo Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Subcutaneous Injection Products, Services and Solutions
5.3.4 Sanofi Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Subcutaneous Injection Products, Services and Solutions
5.4.4 Roche Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 GSK
5.5.1 GSK Profile
5.5.2 GSK Main Business
5.5.3 GSK Subcutaneous Injection Products, Services and Solutions
5.5.4 GSK Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.5.5 GSK Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Subcutaneous Injection Products, Services and Solutions
5.6.4 Eli Lilly Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Asahi Kasei Pharma
5.7.1 Asahi Kasei Pharma Profile
5.7.2 Asahi Kasei Pharma Main Business
5.7.3 Asahi Kasei Pharma Subcutaneous Injection Products, Services and Solutions
5.7.4 Asahi Kasei Pharma Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.7.5 Asahi Kasei Pharma Recent Developments
5.8 Takeda Pharmaceutical
5.8.1 Takeda Pharmaceutical Profile
5.8.2 Takeda Pharmaceutical Main Business
5.8.3 Takeda Pharmaceutical Subcutaneous Injection Products, Services and Solutions
5.8.4 Takeda Pharmaceutical Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.8.5 Takeda Pharmaceutical Recent Developments
5.9 Antares Pharma, Inc.
5.9.1 Antares Pharma, Inc. Profile
5.9.2 Antares Pharma, Inc. Main Business
5.9.3 Antares Pharma, Inc. Subcutaneous Injection Products, Services and Solutions
5.9.4 Antares Pharma, Inc. Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.9.5 Antares Pharma, Inc. Recent Developments
5.10 Eisai Co.，Ltd
5.10.1 Eisai Co.，Ltd Profile
5.10.2 Eisai Co.，Ltd Main Business
5.10.3 Eisai Co.，Ltd Subcutaneous Injection Products, Services and Solutions
5.10.4 Eisai Co.，Ltd Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.10.5 Eisai Co.，Ltd Recent Developments
5.11 Chugai Pharmaceutical
5.11.1 Chugai Pharmaceutical Profile
5.11.2 Chugai Pharmaceutical Main Business
5.11.3 Chugai Pharmaceutical Subcutaneous Injection Products, Services and Solutions
5.11.4 Chugai Pharmaceutical Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.11.5 Chugai Pharmaceutical Recent Developments
5.12 Endo International
5.12.1 Endo International Profile
5.12.2 Endo International Main Business
5.12.3 Endo International Subcutaneous Injection Products, Services and Solutions
5.12.4 Endo International Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.12.5 Endo International Recent Developments
5.13 PenJet Corporation
5.13.1 PenJet Corporation Profile
5.13.2 PenJet Corporation Main Business
5.13.3 PenJet Corporation Subcutaneous Injection Products, Services and Solutions
5.13.4 PenJet Corporation Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.13.5 PenJet Corporation Recent Developments
5.14 Aspen Medical Group
5.14.1 Aspen Medical Group Profile
5.14.2 Aspen Medical Group Main Business
5.14.3 Aspen Medical Group Subcutaneous Injection Products, Services and Solutions
5.14.4 Aspen Medical Group Subcutaneous Injection Revenue (US$ Million) & (2018-2023)
5.14.5 Aspen Medical Group Recent Developments
6 North America
6.1 North America Subcutaneous Injection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Subcutaneous Injection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Injection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Subcutaneous Injection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Injection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Subcutaneous Injection Market Dynamics
11.1 Subcutaneous Injection Industry Trends
11.2 Subcutaneous Injection Market Drivers
11.3 Subcutaneous Injection Market Challenges
11.4 Subcutaneous Injection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
